Engineered Cell Therapies and Antibodies

Synthetic biology will play an important role in advancing adoptive T cell therapy. Engineered receptors and genetic circuits can make cell-based therapies safer and more powerful. Cellular engineering and genome editing can further improve the T cell as a frame work for therapy.The adoptive transfer of genetically engineered T cells with cancer-targeting receptors has shown tremendous promise for eradicating tumors in clinical trials. This form of cellular immunotherapy presents a unique opportunity to incorporate advanced systems and synthetic biology approaches to create cancer therapeutics with Here novel functions.
 
Here are certain engineered cell therapy which are engineered .
  • Chimeric Antigen Receptor
  • Monoclonal Antibody
  • Adoptive Cell Transfer
  • Gene Therapy

Related Conference of Engineered Cell Therapies and Antibodies

Engineered Cell Therapies and Antibodies Conference Speakers